{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:40:13Z","timestamp":1788565213206,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hui Ye","award":["GZWKJ2022-080"],"award-info":[{"award-number":["GZWKJ2022-080"]}]},{"name":"Ying Hu","award":["GZWKJ2022-001"],"award-info":[{"award-number":["GZWKJ2022-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75750-1","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:28:36Z","timestamp":1735583316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Xue","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengcan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"1","key":"75750_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng, R. et al. Cancer incidence and mortality in China, 2016. J. Natl. Cancer Center 2(1), 1\u20139 (2022).","journal-title":"J. National Cancer Center"},{"issue":"1","key":"75750_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. 2023 Cancer statistics. CA Cancer J. Clin. 73(1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"10061","key":"75750_CR3","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas, M. E., McFadden, D. G. & Durante, C. Thyroid cancer. Lancet (London, England) 388(10061), 2783\u20132795 (2016).","journal-title":"Lancet (London, England)"},{"issue":"1","key":"75750_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi, G. et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr. Pathol. 33(1), 115\u2013154 (2022).","journal-title":"Endocr. Pathol."},{"issue":"6","key":"75750_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3322\/caac.21195","volume":"63","author":"DF Schneider","year":"2013","unstructured":"Schneider, D. F. & Chen, H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J. Clin. 63(6), 374\u2013394 (2013).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"75750_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.20892\/j.issn.2095-3941.2018.0125","volume":"16","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: A study of 1,587 patients. Cancer Biol. Med. 16(1), 121\u2013130 (2019).","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"75750_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21053\/ceo.2016.9.1.75","volume":"9","author":"SY Choi","year":"2016","unstructured":"Choi, S. Y. et al. Metastatic lymph node ratio of central neck compartment has predictive values for locoregional recurrence in papillary thyroid microcarcinoma. Clin. Exp. Otorhinolaryngol. 9(1), 75\u201379 (2016).","journal-title":"Clin. Exp. Otorhinolaryngol."},{"issue":"5","key":"75750_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144(5), 646\u2013674 (2011).","journal-title":"Cell"},{"key":"75750_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.570604","volume":"11","author":"Z Xie","year":"2020","unstructured":"Xie, Z. et al. Immune cell confrontation in the papillary thyroid carcinoma microenvironment. Front. Endocrinol. 11, 570604 (2020).","journal-title":"Front. Endocrinol."},{"issue":"5","key":"75750_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24(5), 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"75750_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: Positioning cells for host defense and immunity. Ann. Rev. Immunol. 32, 659\u2013702 (2014).","journal-title":"Ann. Rev. Immunol."},{"issue":"2","key":"75750_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","volume":"13","author":"AP Vicari","year":"2002","unstructured":"Vicari, A. P. & Caux, C. Chemokines in cancer. Cytokine Growth Factor Rev. 13(2), 143\u2013154 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"75750_CR13","first-page":"95","volume":"1","author":"Y Le","year":"2004","unstructured":"Le, Y. et al. Chemokines and chemokine receptors: Their manifold roles in homeostasis and disease. Cell. Molecular Immunol. 1(2), 95\u2013104 (2004).","journal-title":"Cell. Molecular Immunol."},{"issue":"35","key":"75750_CR14","doi-asserted-by":"publisher","first-page":"21514","DOI":"10.1074\/jbc.271.35.21514","volume":"271","author":"T Imai","year":"1996","unstructured":"Imai, T. et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 271(35), 21514\u201321521 (1996).","journal-title":"J. Biol. Chem."},{"issue":"23","key":"75750_CR15","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","volume":"272","author":"T Imai","year":"1997","unstructured":"Imai, T. et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272(23), 15036\u201315042 (1997).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"75750_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25(12), 677\u2013686 (2004).","journal-title":"Trends Immunol."},{"issue":"10","key":"75750_CR17","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/ijc.23392","volume":"122","author":"Y Mizukami","year":"2008","unstructured":"Mizukami, Y. et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int. J. Cancer 122(10), 2286\u20132293 (2008).","journal-title":"Int. J. Cancer"},{"issue":"2","key":"75750_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12032-016-0729-9","volume":"33","author":"F Zhu","year":"2016","unstructured":"Zhu, F. et al. Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma. Med. Oncol. (Northwood, London, England) 33(2), 17 (2016).","journal-title":"Med. Oncol. (Northwood, London, England)"},{"issue":"10","key":"75750_CR19","first-page":"3072","volume":"5","author":"LB Liu","year":"2015","unstructured":"Liu, L. B. et al. Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell. Am. J. Cancer Res. 5(10), 3072\u20133084 (2015).","journal-title":"Am. J. Cancer Res."},{"key":"75750_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.816927","volume":"10","author":"T Ye","year":"2022","unstructured":"Ye, T. et al. Chemokine CCL17 affects local immune infiltration characteristics and early prognosis value of lung adenocarcinoma. Front. Cell Dev. Biol. 10, 816927 (2022).","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"75750_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00384-023-04462-1","volume":"38","author":"AA Al-haidari","year":"2023","unstructured":"Al-haidari, A. A. et al. Retraction Note: CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA\/Rho-kinase signaling. Int. J. Colorectal Dis. 38(1), 165 (2023).","journal-title":"Int. J. Colorectal Dis."},{"issue":"W1","key":"75750_CR22","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98-w102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"75750_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.821958","volume":"12","author":"Y Cui","year":"2022","unstructured":"Cui, Y. et al. Transcriptional expressions of ALDH1A1\/B1 as independent indicators for the survival of thyroid cancer patients. Front. Oncol. 12, 821958 (2022).","journal-title":"Front. Oncol."},{"issue":"20","key":"75750_CR24","first-page":"4200","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: An integrated repository portal for tumor-immune system interactions. Bioinformatics (Oxford, England) 35(20), 4200\u20134202 (2019).","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"12","key":"75750_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(12), 550 (2014).","journal-title":"Genome Biol."},{"key":"75750_CR26","doi-asserted-by":"crossref","unstructured":"Subramanian, A., Tamayo, P., Mootha, V. K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. In: Proceedings of the National Academy of Sciences of the United States of America, 102(43): 15545-50, (2005).","DOI":"10.1073\/pnas.0506580102"},{"issue":"4","key":"75750_CR27","first-page":"4351","volume":"15","author":"W Liu","year":"2018","unstructured":"Liu, W. et al. Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer. Oncol. Lett. 15(4), 4351\u20134357 (2018).","journal-title":"Oncol. Lett."},{"key":"75750_CR28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"75750_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen, B. et al. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Molecular Biol (Clifton, NJ) 1711, 243\u2013259 (2018).","journal-title":"Methods Molecular Biol (Clifton, NJ)"},{"issue":"21","key":"75750_CR30","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77(21), e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"issue":"3","key":"75750_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"75750_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/thy.2013.0257","volume":"24","author":"R Udelsman","year":"2014","unstructured":"Udelsman, R. & Zhang, Y. The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds. Thyroid Off. J Am. Thyroid Ass. 24(3), 472\u2013479 (2014).","journal-title":"Thyroid Off. J Am. Thyroid Ass."},{"key":"75750_CR33","volume":"347","author":"JP Brito","year":"2013","unstructured":"Brito, J. P., Morris, J. C. & Montori, V. M. Thyroid cancer: Zealous imaging has increased detection and treatment of low risk tumours. BMJ (Clinical research ed) 347, f4706 (2013).","journal-title":"BMJ (Clinical research ed)"},{"issue":"30","key":"75750_CR34","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1200\/JCO.2016.67.7419","volume":"34","author":"L Furuya-Kanamori","year":"2016","unstructured":"Furuya-Kanamori, L. et al. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: A meta-analysis. J. Clin. Oncol. Offi. J Am. Soc. Clin. Oncol. 34(30), 3672\u20133679 (2016).","journal-title":"J. Clin. Oncol. Offi. J Am. Soc. Clin. Oncol."},{"issue":"24","key":"75750_CR35","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMc1507622","volume":"373","author":"HS Ahn","year":"2015","unstructured":"Ahn, H. S. & Welch, H. G. South Korea\u2019s thyroid-cancer \u201cEpidemic\u201d\u2013turning the tide. N. Engl. J. Med. 373(24), 2389\u20132390 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"75750_CR36","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan, F., Dedhia, P. H. & Ringel, M. D. Thyroid cancer, recent advances in diagnosis and therapy. Int. J. Cancer 149(5), 984\u2013992 (2021).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"75750_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible, K. C. et al. 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid Off. J. Am. Thyroid Ass. 31(3), 337\u2013386 (2021).","journal-title":"Thyroid Off. J. Am. Thyroid Ass."},{"issue":"6","key":"75750_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.bj.2021.11.009","volume":"45","author":"JH Sun","year":"2022","unstructured":"Sun, J. H. et al. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan. Biomed. J. 45(6), 923\u2013930 (2022).","journal-title":"Biomed. J."},{"issue":"2","key":"75750_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12022-020-09653-y","volume":"32","author":"B Aydo\u011fan","year":"2021","unstructured":"Aydo\u011fan, B. et al. The association of histologically proven chronic lymphocytic thyroiditis with clinicopathological features, lymph node metastasis, and recurrence rates of differentiated thyroid cancer. Endocrine Pathol. 32(2), 280\u2013287 (2021).","journal-title":"Endocrine Pathol."},{"issue":"21","key":"75750_CR40","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki, J. et al. CC Chemokines in a Tumor: A review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4. Int. J. Molecular Sci. 21(21), 8412. https:\/\/doi.org\/10.3390\/ijms21218412 (2020).","journal-title":"Int. J. Molecular Sci."},{"issue":"3","key":"75750_CR41","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","volume":"273","author":"T Imai","year":"1998","unstructured":"Imai, T. et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273(3), 1764\u20131768 (1998).","journal-title":"J. Biol. Chem."},{"issue":"9","key":"75750_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-023-06108-0","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17\/CXCL22-CCR4-ATF6-GRP78 axis. Cell Death Dis. 14(9), 582 (2023).","journal-title":"Cell Death Dis."},{"issue":"7","key":"75750_CR43","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou, S. L. et al. Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology 150(7), 1646\u201358.e17 (2016).","journal-title":"Gastroenterology"},{"issue":"1","key":"75750_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s12885-017-3663-0","volume":"17","author":"SH Omland","year":"2017","unstructured":"Omland, S. H. et al. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin. BMC Cancer 17(1), 675 (2017).","journal-title":"BMC Cancer"},{"issue":"1","key":"75750_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/intimm\/dxu079","volume":"27","author":"O Yoshie","year":"2015","unstructured":"Yoshie, O. & Matsushima, K. CCR4 and its ligands: From bench to bedside. Int. Immunol. 27(1), 11\u201320 (2015).","journal-title":"Int. Immunol."},{"issue":"4","key":"75750_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.cgt.7700903","volume":"13","author":"N Okada","year":"2006","unstructured":"Okada, N. et al. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector. Cancer Gene Therapy 13(4), 393\u2013405 (2006).","journal-title":"Cancer Gene Therapy"},{"issue":"9","key":"75750_CR47","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/ijc.22908","volume":"121","author":"N Kanagawa","year":"2007","unstructured":"Kanagawa, N. et al. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int. J. Cancer 121(9), 2013\u20132022 (2007).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"75750_CR48","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ijc.28770","volume":"135","author":"I Mishalian","year":"2014","unstructured":"Mishalian, I. et al. Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17\u2013a new mechanism of impaired antitumor immunity. Int. J. Cancer 135(5), 1178\u20131186 (2014).","journal-title":"Int. J. Cancer"},{"issue":"7","key":"75750_CR49","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-08-2641","volume":"15","author":"XJ Qin","year":"2009","unstructured":"Qin, X. J. et al. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin. Cancer Res. Off. J. Am. Ass. Cancer Res. 15(7), 2231\u20132237 (2009).","journal-title":"Clin. Cancer Res. Off. J. Am. Ass. Cancer Res."},{"issue":"5","key":"75750_CR50","first-page":"422","volume":"23","author":"T Maruyama","year":"2010","unstructured":"Maruyama, T. et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Dis. Esophagus Off. J. Int. Soc. Dis. Esophagus 23(5), 422\u2013429 (2010).","journal-title":"Dis. Esophagus Off. J. Int. Soc. Dis. Esophagus"},{"issue":"1","key":"75750_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbrc.2017.05.034","volume":"488","author":"W Liu","year":"2017","unstructured":"Liu, W. et al. CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF-\u03b2 pathway in human non-small cell lung cancer. Biochem. Biophys. Res. Commun. 488(1), 196\u2013203 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"75750_CR52","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1038\/s41598-019-40514-9","volume":"9","author":"JK Thomas","year":"2019","unstructured":"Thomas, J. K. et al. CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival. Sci. Rep. 9(1), 4014 (2019).","journal-title":"Sci. Rep."},{"issue":"8","key":"75750_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41416-019-0559-6","volume":"121","author":"T Kuwahara","year":"2019","unstructured":"Kuwahara, T. et al. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer. Br. J. Cancer 121(8), 659\u2013665 (2019).","journal-title":"Br. J. Cancer"},{"issue":"10","key":"75750_CR54","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/sj.bjc.6601400","volume":"89","author":"EJ Bromwich","year":"2003","unstructured":"Bromwich, E. J. et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br. J. Cancer 89(10), 1906\u20131908 (2003).","journal-title":"Br. J. Cancer"},{"issue":"11","key":"75750_CR55","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/annonc\/mdw319","volume":"27","author":"T Kinoshita","year":"2016","unstructured":"Kinoshita, T. et al. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 27(11), 2117\u20132123 (2016).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"75750_CR56","doi-asserted-by":"publisher","first-page":"101410","DOI":"10.1016\/j.smim.2020.101410","volume":"48","author":"J Verneau","year":"2020","unstructured":"Verneau, J., Saut\u00e9s-Fridman, C. & Sun, C. M. Dendritic cells in the tumor microenvironment: Prognostic and theranostic impact. Sem. Immunol. 48, 101410 (2020).","journal-title":"Sem. Immunol."},{"issue":"4","key":"75750_CR57","first-page":"376","volume":"4","author":"JG Quatromoni","year":"2012","unstructured":"Quatromoni, J. G. & Eruslanov, E. Tumor-associated macrophages: Function, phenotype, and link to prognosis in human lung cancer. Am. J. Trans. Res. 4(4), 376\u2013389 (2012).","journal-title":"Am. J. Trans. Res."},{"issue":"9","key":"75750_CR58","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10(9), 942\u2013949 (2004).","journal-title":"Nat. Med."},{"issue":"5","key":"75750_CR59","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1210\/jc.2009-2564","volume":"95","author":"JD French","year":"2010","unstructured":"French, J. D. et al. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J. Clin. Endocrinol. Metabol. 95(5), 2325\u20132333 (2010).","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"8","key":"75750_CR60","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1089\/thy.2013.0423","volume":"24","author":"HS Ryu","year":"2014","unstructured":"Ryu, H. S. et al. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma. Thyroid Off. J Am. Thyroid Ass. 24(8), 1232\u20131240 (2014).","journal-title":"Thyroid Off. J Am. Thyroid Ass."},{"issue":"6216","key":"75750_CR61","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.aaa1292","volume":"346","author":"Y Maeda","year":"2014","unstructured":"Maeda, Y. et al. Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals. Science (New York, NY) 346(6216), 1536\u20131540 (2014).","journal-title":"Science (New York, NY)"},{"issue":"6","key":"75750_CR62","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.smim.2011.10.002","volume":"23","author":"T Yamaguchi","year":"2011","unstructured":"Yamaguchi, T., Wing, J. B. & Sakaguchi, S. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Sem. Immunol. 23(6), 424\u2013430 (2011).","journal-title":"Sem. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75750-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T09:05:33Z","timestamp":1735635933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75750"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75750-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by the institutional ethics board of the Affiliated Hospital of Guizhou Medical University. The patients\/participants provided their written informed consent to participate in this study.\u00a0We confirm that all research was performed in accordance with relevant guidelines\/regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors consent to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"31580"}}